FIELD: medicine, immunology. SUBSTANCE: invention relates to new preparations containing immunoreactive proteins that can be used for prophylaxis and/or treatment of septic shock. Invention relates to the product containing G-CSF or its pharmaceutically acceptable salt and TNF-binding protein or its pharmaceutically acceptable salt. This agent can be used for treatment and/or prophylaxis of septic shock. EFFECT: broadened arsenal of immunoreactive protein agents. 13 cl, 2 tbl, 1 ex
Authors
Dates
1999-10-10—Published
1995-02-02—Filed